Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease renal cell carcinoma
Comorbidity C0032285|pneumonitis
Sentences 6
PubMedID- 22689175 Incidence and management of mtor inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma.
PubMedID- 24053120 Mammalian target of rapamycin (mtor) inhibitor-associated non-infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes.
PubMedID- 21444868 Drug-related pneumonitis in patients with advanced renal cell carcinoma treated with temsirolimus.
PubMedID- 21356651 Noninfectious pneumonitis in a patient with renal cell carcinoma treated with everolimus.
PubMedID- 25342378 The purpose of this study is to compare the adverse event profiles of both agents and to estimate the risk factors for non-infectious pneumonitis in patients with advanced renal cell carcinoma on the basis of our real-world clinical experience.
PubMedID- 25275080 Changes in the diffusion capacity for carbon monoxide and the development of non-infectious pneumonitis in patients with metastatic renal cell carcinoma treated with everolimus.

Page: 1